XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Total
Balance at beginning of period at Dec. 31, 2022 $ 122,000 $ 42,445,000 $ 543,875,000 $ (53,355,000)   $ 533,087,000
Net income     20,456,000     20,456,000
Stock issued under Stock Option Plan   425,000     $ 45,000 470,000
Common cash dividends declared     (4,854,000)     (4,854,000)
Change in fair value of cash flow hedges       5,029,000   5,029,000
Change in unrealized loss on held-to-maturity securities       (17,000)   (17,000)
Change in unrealized gain on available-for-sale securities       6,915,000   6,915,000
Purchase of the Company's common stock         (5,575,000) (5,575,000)
Reclassification of treasury stock per Maryland law (1,000)   (5,529,000)   5,530,000  
Balance at ending of period at Mar. 31, 2023 121,000 42,870,000 553,948,000 (41,428,000)   555,511,000
Balance at beginning of period at Dec. 31, 2023 118,000 44,320,000 569,872,000 (42,481,000)   571,829,000
Net income     13,407,000     13,407,000
Stock issued under Stock Option Plan   487,000     205,000 692,000
Common cash dividends declared     (4,680,000)     (4,680,000)
Change in fair value of cash flow hedges       (4,532,000)   (4,532,000)
Change in unrealized loss on held-to-maturity securities       (36,000)   (36,000)
Change in unrealized gain on available-for-sale securities       (5,460,000)   (5,460,000)
Purchase of the Company's common stock         (5,835,000) (5,835,000)
Reclassification of treasury stock per Maryland law (1,000)   (5,629,000)   $ 5,630,000  
Balance at ending of period (Accounting Standards Update 2023-02) at Mar. 31, 2024     (223,000)     (223,000)
Balance at ending of period at Mar. 31, 2024 $ 117,000 $ 44,807,000 $ 572,747,000 $ (52,509,000)   $ 565,162,000